Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.
Latest SPAC News: Rumble launches beta version of ad platform, and ZyVersa demonstrates effectiveness of inflammsome
Rumble Launches Beta Version of Ad Platform
Today, the video-sharing platform Rumble announced the launch of the beta version of Rumble Ads, which will be open to all verified businesses.
The beta version of the new platform will allow advertisers to access a portion of the user traffic on Rumble’s website, create campaigns, view analytics, and much more. The platform will be launched initially for display advertisements, with video and native advertisements to follow in the next quarter. The platform also supports the ability for Publishers to access advertiser demand. Select Publishers will be granted access to the Beta version of the platform this quarter.
The company announced in December 2021 the execution of a definitive business combination agreement with CF Acquisition Corp. VI (NASDAQ: CFVI).
READ
Data Published in Frontiers in Molecular Neuroscience Demonstrate That ZyVersa’s Inflammasome ASC Inhibitor, IC 100, Is Effective in Reducing Brain Inflammation in a Preclinical Model of Aging
ZyVersa Therapeutics, Inc., a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, and Larkspur Health Acquisition Corp. (NASDAQ: LSPR), a blank-check special purpose acquisition company, are pleased to announce that data published in Frontiers in Molecular Neuroscience demonstrate that ZyVersa’s inflammasome ASC inhibitor, IC 100, is effective in reducing inflammation in the brains of aged mice.
Age-related chronic inflammation is implicated in development and progression of neurodegenerative diseases, such as Alzheimer’s and Parkinson’s diseases. The research was conducted by renowned scientists from the University of MiamiMiller School of Medicine, Dr. Juan Pablo de Rivero Vaccari and Dr. Robert W. Keane.
READ
Terms Tracker for the Week Ending January 27, 2022 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. We’re coming up on the end of January, the first month of the year, and to-date no new S-1s have been filed. Additionally, the number...
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. Latest SPAC News: Circle spokesperson denies blaming SEC for failed deal, BuzzFeed CEO says AI-powered content will be part of core business, and FaZe Clan faces possible delisting Circle Spokesperson Denies Blaming SEC for Failed $9 Billion Deal...
Health Sciences 2 (NASDAQ:HSAQ) announced that it closed its combination with Orchestra BioMed on January 26. HSAQ ahead of its vote pre-announced redemption figures of 1,597,888 shares equating to 67.7% redemptions, however, that’s still subject to change. However, today it was noted that Orchestra BioMed is to receive $70 million in gross proceeds including $20...
Carbon capture technology has long been talked about, and it is finally in operation with LanzaTech among the pioneers. Its plants are turning potential emissions into clothing, household goods and sustainable fuels. SPAC cash is now also an accelerant in this new process as the company announced a $1.7 billion combination with AMCI II last March. This week, we caught up with...
In this series we’ll be examining successful SPAC deals from the past both in the terms and circumstances of their de-SPAC processes and how they have weathered the storms that have followed after their public listings with research from SPACInsider contributor Anthony Sozzi. Thirty months does not sound like that long, but it’s been a...